The line separating cancer and cancer-free isn't always thick and dark.
PUBLISHED September 30, 2018
Stacie Chevrier is a recovering type-A, corporate climber who made a big life change after being diagnosed with cancer in September 2014. She now spends her days focusing on writing, fitness and healthy living. Outside of these passions, Stacie can be found practicing yoga, enjoying anything outdoors, traveling and defying the odds as a pancreatic neuroendocrine tumor survivor.
Those of us in cancerland know that cancer isn't always black or white, and the line separating cancer and cancer-free isn't always thick and dark. We know that the word remission is a bit taboo, so the goal of this post is to educate the cancer muggles on the gray area where this disease can sometimes rest.
After being diagnosed with a pancreatic neuroendocrine tumor in September 2014, I underwent surgeries and treatments until my body showed no evidence of disease (a favorite term among oncologists). I went along for a yeacrossing my fingers the illness would leave my life, but also knowing the statistics behind this cancer and that it would probably make an appearance again.
During those months, I was free of any signs of disease, when a questionable spot popped up in my liver. Radiologists debated whether it was contrast build up, a new tumor, but even the tumor board (an oversight committee) couldn't come up with a definitive conclusion. My (usually very sensitive) tumor marker remained normal, so they threw me into a dreaded strategy of, "watch and wait."
After being diagnosed with a pancreatic neuroendocrine tumor in September 2014, I underwent surgeries and treatments until my body showed no evidence of disease (a favorite term among oncologists). I went along for a yeacrossing my fingers the illness would leave my life, but also knowing the statistics behind this cancer and that it would probably make an appearance again.
During those months, I was free of any signs of disease, when a questionable spot popped up in my liver. Radiologists debated whether it was contrast build up, a new tumor, but even the tumor board (an oversight committee) couldn't come up with a definitive conclusion. My (usually very sensitive) tumor marker remained normal, so they threw me into a dreaded strategy of, "watch and wait."
No comments:
Post a Comment